28 participants
Pharmacokinetics and Safety Pilot Study of Single-Dose Oral and Intravenous CTAP101 in Stage 3 and 4 Chronic Kidney Disease Subjects
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2014-09-30
- Start Date:
- 2009-05-31
- Completion:
- 2009-11-30
Conditions
- Chronic Kidney Disease
- Secondary Hyperparathyroidism
- Chronic Renal Insufficiency
- Chronic Renal Failure
Interventions
- DRUG
No Results Yet